Lytix Biopharma Considers Private Placement, Retail Offer

MT Newswires · 3d ago
11:40 AM EST, 11/17/2026 (MT Newswires) -- Lytix Biopharma (LYTIX.OL) is considering a private placement of new shares and a separate retail offer to fund clinical trial preparations and working capital, according to a Tuesday release. The clinical-stage biotechnology company aims to raise 60 million Norwegian kroner to 80 million kroner through the private placement, with applications closing Wednesday. DNB Carnegie will manage the offering, which has a minimum order size of 100,000 euros in kroner equivalent. Meanwhile, the retail offer, facilitated by Nordnet Bank, aims to raise up to 1 million euros in kroner equivalent. Both offerings are priced at 8 kroner per share.